{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T03:24:37Z","timestamp":1786937077236,"version":"build-2736575974"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Science and Technology Council"},{"name":"Chang Gung University of Science and Technology Chang Gung University of Science Foundation"},{"DOI":"10.13039\/501100004319","name":"Shin Kong Wu Ho-Su Memorial Hospital","doi-asserted-by":"publisher","award":["2026SKHADR017"],"award-info":[{"award-number":["2026SKHADR017"]}],"id":[{"id":"10.13039\/501100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chang Gung Medical Research Program Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lung cancer is a leading cause of cancer-related mortality, with metastasis significantly reducing patient survival. Interleukin 11 (IL11), a member of the IL-6 cytokine family, has been associated with cancer progression, yet its role in non-small cell lung cancer (NSCLC) metastasis remains unclear. This study analyzed public datasets and demonstrated that IL11 is upregulated in NSCLC and correlates with lymphatic metastasis and poor prognosis. Functional assays revealed that IL11 enhances lung cancer cell migration through upregulation of matrix metalloproteinase 12 (MMP12). Mechanistically, IL11 acts via the IL11 receptor subunit alpha (IL11RA)\/ IL6 cytokine family signal transducer (IL6ST) complex to activate the PI3K\/Akt\/NF-\u03baB signaling pathway, which in turn drives MMP12 expression and promotes metastatic behavior. Notably, the clinically approved selective estrogen receptor modulator bazedoxifene effectively inhibited IL11-induced signaling, reduced MMP12 levels, and suppressed cancer cell migration in vitro. In an orthotopic lung cancer mouse model, IL11 knockdown significantly reduced tumor growth and intrapulmonary spread, accompanied by decreased IL11, MMP12, and phosphorylated NF-\u03baB p65 levels in lung tissues. These findings uncover a novel IL11-driven pathway contributing to metastatic behavior in NSCLC and identify the IL11\/IL11RA\/IL6ST axis as a potential therapeutic target.<\/jats:p>","DOI":"10.1038\/s41420-026-03163-2","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T06:02:57Z","timestamp":1781157777000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["IL11 modulates MMP12 expression and cancer cell metastasis via IL11RA\/IL6ST-PI3K\/Akt\/NF-\u03baB pathway in lung cancer"],"prefix":"10.1038","volume":"12","author":[{"given":"Chiang-Wen","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Sen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Ming","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zih-Chan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Chang","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao-Ching","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Ti","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Ling","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0887-6096","authenticated-orcid":false,"given":"Ju-Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"3163_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01740-y","volume":"22","author":"A Lahiri","year":"2023","unstructured":"Lahiri A, Maji A, Potdar PD, Singh N, Parikh P, Bisht B, et al. Lung cancer immunotherapy: progress, pitfalls, and promises. Mol Cancer. 2023;22:40.","journal-title":"Mol Cancer"},{"key":"3163_CR2","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10:1243\u201360.","journal-title":"J Thorac Oncol"},{"key":"3163_CR3","doi-asserted-by":"publisher","first-page":"340","DOI":"10.6004\/jnccn.2023.0020","volume":"21","author":"DS Ettinger","year":"2023","unstructured":"Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, et al. NCCN guidelines(R) insights: non-small cell lung cancer, version 2.2023. J Natl Compr Canc Netw. 2023;21:340\u201350.","journal-title":"J Natl Compr Canc Netw"},{"key":"3163_CR4","first-page":"7","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"3163_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10555-015-9562-4","volume":"34","author":"X Wang","year":"2015","unstructured":"Wang X, Adjei AA. Lung cancer and metastasis: new opportunities and challenges. Cancer Metastasis Rev. 2015;34:169\u201371.","journal-title":"Cancer Metastasis Rev"},{"key":"3163_CR6","doi-asserted-by":"crossref","unstructured":"Bhat GR, Sethi I, Sadida HQ, Rah B, Mir R, Algehainy N, et al. Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance. Cancer Metastasis Rev. 2024;43:197\u2013228.","DOI":"10.1007\/s10555-024-10172-z"},{"key":"3163_CR7","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/s43018-023-00595-y","volume":"4","author":"A Perez-Gonzalez","year":"2023","unstructured":"Perez-Gonzalez A, Bevant K, Blanpain C. Cancer cell plasticity during tumor progression, metastasis and response to therapy. Nat Cancer. 2023;4:1063\u201382.","journal-title":"Nat Cancer"},{"key":"3163_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01428-1","volume":"20","author":"X Mao","year":"2021","unstructured":"Mao X, Xu J, Wang W, Liang C, Hua J, Liu J, et al. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer. 2021;20:131.","journal-title":"Mol Cancer"},{"key":"3163_CR9","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41571-025-01021-1","volume":"22","author":"Z Rahal","year":"2025","unstructured":"Rahal Z, El Darzi R, Moghaddam SJ, Cascone T, Kadara H. Tumour and microenvironment crosstalk in NSCLC progression and response to therapy. Nat Rev Clin Oncol. 2025;22:463\u201382.","journal-title":"Nat Rev Clin Oncol"},{"key":"3163_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1195426","volume":"13","author":"C Wei","year":"2023","unstructured":"Wei C. The multifaceted roles of matrix metalloproteinases in lung cancer. Front Oncol. 2023;13:1195426.","journal-title":"Front Oncol"},{"key":"3163_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1325095","volume":"13","author":"N Sampaio Moura","year":"2023","unstructured":"Sampaio Moura N, Schledwitz A, Alizadeh M, Patil SA, Raufman JP. Matrix metalloproteinases as biomarkers and therapeutic targets in colitis-associated cancer. Front Oncol. 2023;13:1325095.","journal-title":"Front Oncol"},{"key":"3163_CR12","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41577-018-0066-7","volume":"18","author":"SA Jones","year":"2018","unstructured":"Jones SA, Jenkins BJ. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer. Nat Rev Immunol. 2018;18:773\u201389.","journal-title":"Nat Rev Immunol"},{"key":"3163_CR13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.smim.2014.01.001","volume":"26","author":"K Taniguchi","year":"2014","unstructured":"Taniguchi K, Karin M. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer. Semin Immunol. 2014;26:54\u201374.","journal-title":"Semin Immunol"},{"key":"3163_CR14","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2217\/imt.15.17","volume":"7","author":"TL Putoczki","year":"2015","unstructured":"Putoczki TL, Ernst M. IL-11 signaling as a therapeutic target for cancer. Immunotherapy. 2015;7:441\u201353.","journal-title":"Immunotherapy"},{"key":"3163_CR15","doi-asserted-by":"crossref","unstructured":"Maroni P, Bendinelli P, Ferraretto A, Lombardi G. Interleukin 11 (IL-11): role(s) in breast cancer bone metastases. Biomedicines. 2021;9:659.","DOI":"10.3390\/biomedicines9060659"},{"key":"3163_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1594-1","volume":"10","author":"M Liang","year":"2019","unstructured":"Liang M, Ma Q, Ding N, Luo F, Bai Y, Kang F, et al. IL-11 is essential in promoting osteolysis in breast cancer bone metastasis via RANKL-independent activation of osteoclastogenesis. Cell Death Dis. 2019;10:353.","journal-title":"Cell Death Dis"},{"key":"3163_CR17","doi-asserted-by":"crossref","unstructured":"To SQ, Dmello RS, Richards AK, Ernst M, Chand AL. STAT3 signaling in breast cancer: multicellular actions and therapeutic potential. Cancers. 2022;14:429.","DOI":"10.3390\/cancers14020429"},{"key":"3163_CR18","doi-asserted-by":"crossref","unstructured":"Zhou Z, Wang P, Sun R, Li J, Hu Z, Xin H, et al. Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3. J Immunother Cancer. 2021;9:e001946.","DOI":"10.1136\/jitc-2020-001946"},{"key":"3163_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41416-019-0483-9","volume":"121","author":"Q Al-Ismaeel","year":"2019","unstructured":"Al-Ismaeel Q, Neal CP, Al-Mahmoodi H, Almutairi Z, Al-Shamarti I, Straatman K, et al. ZEB1 and IL-6\/11-STAT3 signalling cooperate to define invasive potential of pancreatic cancer cells via differential regulation of the expression of S100 proteins. Br J Cancer. 2019;121:65\u201375.","journal-title":"Br J Cancer"},{"key":"3163_CR20","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ymthe.2018.12.015","volume":"27","author":"Z Chen","year":"2019","unstructured":"Chen Z, Chen X, Xie R, Huang M, Dong W, Han J, et al. DANCR promotes metastasis and proliferation in bladder cancer cells by enhancing IL-11-STAT3 signaling and CCND1 expression. Mol Ther. 2019;27:326\u201341.","journal-title":"Mol Ther"},{"key":"3163_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21976-w","volume":"12","author":"B Zhang","year":"2021","unstructured":"Zhang B, Li Y, Wu Q, Xie L, Barwick B, Fu C, et al. Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer. Nat Commun. 2021;12:1714.","journal-title":"Nat Commun"},{"key":"3163_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1366-y","volume":"15","author":"C Zhou","year":"2015","unstructured":"Zhou C, Ji J, Cai Q, Shi M, Chen X, Yu Y, et al. MTA2 enhances colony formation and tumor growth of gastric cancer cells through IL-11. BMC Cancer. 2015;15:343.","journal-title":"BMC Cancer"},{"key":"3163_CR23","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1002\/ijc.24479","volume":"125","author":"M Wysoczynski","year":"2009","unstructured":"Wysoczynski M, Ratajczak MZ. Lung cancer secreted microvesicles: underappreciated modulators of microenvironment in expanding tumors. Int J Cancer. 2009;125:1595\u2013603.","journal-title":"Int J Cancer"},{"key":"3163_CR24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1177\/17246008211023515","volume":"36","author":"J Wu","year":"2021","unstructured":"Wu J, Chen J, Lv X, Yang Q, Yao S, Zhang D, et al. Clinical value of serum and exhaled breath condensate inflammatory factor IL-11 levels in non-small cell lung cancer: clinical value of IL-11 in non-small cell lung cancer. Int J Biol Markers. 2021;36:64\u201376.","journal-title":"Int J Biol Markers"},{"key":"3163_CR25","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.2174\/1871520621666201207091248","volume":"21","author":"N Peng","year":"2021","unstructured":"Peng N, Lu M, Kang M, Liu X, Li B, Dong C. Recombinant human IL-11 promotes lung adenocarcinoma A549 cell growth and EMT through activating STAT3\/HIF-1alpha\/EMT signaling pathway. Anticancer Agents Med Chem. 2021;21:1996\u20132003.","journal-title":"Anticancer Agents Med Chem"},{"key":"3163_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70374","volume":"15","author":"C Cirauqui","year":"2025","unstructured":"Cirauqui C, Ojeda L, Otano I, Pazos I, Santos A, Garrido-Martin EM, et al. Interleukin-11 promotes lung adenocarcinoma tumourigenesis and immune evasion. Clin Transl Med. 2025;15:e70374.","journal-title":"Clin Transl Med"},{"key":"3163_CR27","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1080\/13697137.2019.1568403","volume":"22","author":"JV Pinkerton","year":"2019","unstructured":"Pinkerton JV, Conner EA. Beyond estrogen: advances in tissue selective estrogen complexes and selective estrogen receptor modulators. Climacteric. 2019;22:140\u20137.","journal-title":"Climacteric"},{"key":"3163_CR28","doi-asserted-by":"crossref","unstructured":"Pan L, Shi C, Choi J, Lin J. IL-6 blockade enhances the efficacy of CDK4\/6 inhibitor in BRCA1-mutant triple-negative breast cancer cells. Cells. 2025;14:1602.","DOI":"10.3390\/cells14201602"},{"key":"3163_CR29","doi-asserted-by":"publisher","first-page":"5737","DOI":"10.3390\/curroncol31100426","volume":"31","author":"C Shi","year":"2024","unstructured":"Shi C, Bopp T, Lo HW, Tkaczuk K, Lin J. Bazedoxifene as a potential cancer therapeutic agent targeting IL-6\/GP130 signaling. Curr Oncol. 2024;31:5737\u201351.","journal-title":"Curr Oncol"},{"key":"3163_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/crj.13822","volume":"18","author":"Y Huang","year":"2024","unstructured":"Huang Y, Lin J, Fu X, Li L, Fu S. Bazedoxifene inhibits cell viability, colony-forming activity, and cell migration in human non-small cell lung cancer cells and improves the treatment efficacy of paclitaxel and gemcitabine. Clin Respir J. 2024;18:e13822.","journal-title":"Clin Respir J"},{"key":"3163_CR31","doi-asserted-by":"crossref","unstructured":"Dong J, Lim WW, Shekeran SG, Tan J, Lim SY, Goh JWT, et al. Hepatocyte specific gp130 signalling underlies APAP induced liver injury. Int J Mol Sci. 2022;23:7089.","DOI":"10.3390\/ijms23137089"},{"key":"3163_CR32","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.14336\/AD.2023.0306","volume":"14","author":"B Dong","year":"2023","unstructured":"Dong B, Zhu J, Chen X, Jiang H, Deng Y, Xu L, et al. The emerging role of interleukin-(IL)-11\/IL-11R in bone metabolism and homeostasis: from cytokine to osteokine. Aging Dis. 2023;14:2113\u201326.","journal-title":"Aging Dis"},{"key":"3163_CR33","doi-asserted-by":"publisher","first-page":"4638","DOI":"10.7150\/jca.56185","volume":"12","author":"R Sun","year":"2021","unstructured":"Sun R, Chen C, Deng X, Wang F, Song S, Cai Q, et al. IL-11 mediates the radioresistance of cervical cancer cells via the PI3K\/Akt signaling pathway. J Cancer. 2021;12:4638\u201347.","journal-title":"J Cancer"},{"key":"3163_CR34","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1002\/jcp.30759","volume":"237","author":"S Mirzaei","year":"2022","unstructured":"Mirzaei S, Saghari S, Bassiri F, Raesi R, Zarrabi A, Hushmandi K, et al. NF-kappaB as a regulator of cancer metastasis and therapy response: A focus on epithelial-mesenchymal transition. J Cell Physiol. 2022;237:2770\u201395.","journal-title":"J Cell Physiol"},{"key":"3163_CR35","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.bcp.2008.11.014","volume":"77","author":"CY Huang","year":"2009","unstructured":"Huang CY, Fong YC, Lee CY, Chen MY, Tsai HC, Hsu HC, et al. CCL5 increases lung cancer migration via PI3K, Akt and NF-kappaB pathways. Biochem Pharmacol. 2009;77:794\u2013803.","journal-title":"Biochem Pharmacol"},{"key":"3163_CR36","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13578-021-00677-3","volume":"11","author":"J Qu","year":"2021","unstructured":"Qu J, Li J, Zhang Y, He R, Liu X, Gong K, et al. AKR1B10 promotes breast cancer cell proliferation and migration via the PI3K\/AKT\/NF-kappaB signaling pathway. Cell Biosci. 2021;11:163.","journal-title":"Cell Biosci"},{"key":"3163_CR37","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41420-022-00916-7","volume":"8","author":"O Li","year":"2022","unstructured":"Li O, Zhao C, Zhang J, Li FN, Yang ZY, Liu SL, et al. UBAP2L promotes gastric cancer metastasis by activating NF-kappaB through PI3K\/AKT pathway. Cell Death Discov. 2022;8:123.","journal-title":"Cell Death Discov"},{"key":"3163_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107966","volume":"221","author":"J Yu","year":"2025","unstructured":"Yu J, Qi J, Kong X, Feng Y. Interleukin-11: a central integrative hub driving pathological progression from pulmonary inflammation and fibrosis to cancer. Pharmacol Res. 2025;221:107966.","journal-title":"Pharmacol Res"},{"key":"3163_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pmbts.2017.02.005","volume":"147","author":"N Cui","year":"2017","unstructured":"Cui N, Hu M, Khalil RA. Biochemical and biological attributes of matrix metalloproteinases. Prog Mol Biol Transl Sci. 2017;147:1\u201373.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"3163_CR40","doi-asserted-by":"publisher","first-page":"648","DOI":"10.5483\/BMBRep.2018.51.12.205","volume":"51","author":"L Xu","year":"2018","unstructured":"Xu L, Lu C, Huang Y, Zhou J, Wang X, Liu C, et al. SPINK1 promotes cell growth and metastasis of lung adenocarcinoma and acts as a novel prognostic biomarker. BMB Rep. 2018;51:648\u201353.","journal-title":"BMB Rep"},{"key":"3163_CR41","doi-asserted-by":"publisher","first-page":"e34722","DOI":"10.1097\/MD.0000000000034722","volume":"102","author":"YH Luo","year":"2023","unstructured":"Luo YH, Yuan L, Lu DD, Yang YT, Yang Y, Du YH, et al. The mechanism of dehydroandrographolide inhibiting metastasis in gastric cancer based on network pharmacology and bioinformatics. Medicine. 2023;102:e34722.","journal-title":"Medicine"},{"key":"3163_CR42","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1021\/acs.jproteome.4c00036","volume":"23","author":"A Zuo","year":"2024","unstructured":"Zuo A, Li J, Weng S, Xu H, Zhang Y, Wang L, et al. Integrated exploration of epigenetic dysregulation reveals a stemness\/EMT subtype and MMP12 linked to the progression and prognosis in hepatocellular carcinoma. J Proteome Res. 2024;23:1821\u201333.","journal-title":"J Proteome Res"},{"key":"3163_CR43","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1002\/jcp.30902","volume":"237","author":"CY Wu","year":"2022","unstructured":"Wu CY, Liu JF, Tsai HC, Tzeng HE, Hsieh TH, Wang M, et al. Interleukin-11\/gp130 upregulates MMP-13 expression and cell migration in OSCC by activating PI3K\/Akt and AP-1 signaling. J Cell Physiol. 2022;237:4551\u201362.","journal-title":"J Cell Physiol"},{"key":"3163_CR44","doi-asserted-by":"crossref","unstructured":"Ma YS, Peng SF, Wu RS, Chueh FS, Huang WW, Chen PY, et al. Bisdemethoxycurcumin suppresses human osteosarcoma U\u20112 OS cell migration and invasion via affecting the PI3K\/Akt\/NF\u2011kappaB, PI3K\/Akt\/GSK3beta and MAPK signaling pathways in vitro. Oncol Rep. 2022;48:210.","DOI":"10.3892\/or.2022.8425"},{"key":"3163_CR45","doi-asserted-by":"publisher","first-page":"722","DOI":"10.4149\/neo_2023_230614N310","volume":"70","author":"Y Wang","year":"2023","unstructured":"Wang Y, Li Y, Ran C, Le W, Dong J, Wang X, et al. The gene RAD51AP1 promotes the progression of pancreatic cancer via the PI3K\/Akt\/NF-kappaB signaling pathway. Neoplasma. 2023;70:722\u201332.","journal-title":"Neoplasma"},{"key":"3163_CR46","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/kjm2.12791","volume":"40","author":"YF Zhou","year":"2024","unstructured":"Zhou YF, Li JT, Zheng QL, Ren KL, Yi CC. METTL3-mediated m(6) A methylation of TRAF5 inhibits lung adenocarcinoma cell metastasis via activation of the PI3K\/AKT\/NF-kappaB signaling pathway. Kaohsiung J Med Sci. 2024;40:150\u201360.","journal-title":"Kaohsiung J Med Sci"},{"key":"3163_CR47","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.bmcl.2014.12.065","volume":"25","author":"M Neelgundmath","year":"2015","unstructured":"Neelgundmath M, Dinesh KR, Mohan CD, Li F, Dai X, Siveen KS, et al. Novel synthetic coumarins that targets NF-kappaB in Hepatocellular carcinoma. Bioorg Med Chem Lett. 2015;25:893\u20137.","journal-title":"Bioorg Med Chem Lett"},{"key":"3163_CR48","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s13402-021-00620-1","volume":"44","author":"WY Hung","year":"2021","unstructured":"Hung WY, Lee WJ, Cheng GZ, Tsai CH, Yang YC, Lai TC, et al. Blocking MMP-12-modulated epithelial-mesenchymal transition by repurposing penfluridol restrains lung adenocarcinoma metastasis via uPA\/uPAR\/TGF-beta\/Akt pathway. Cell Oncol. 2021;44:1087\u2013103.","journal-title":"Cell Oncol"},{"key":"3163_CR49","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s10549-019-05183-2","volume":"175","author":"J Tian","year":"2019","unstructured":"Tian J, Chen X, Fu S, Zhang R, Pan L, Cao Y, et al. Bazedoxifene is a novel IL-6\/GP130 inhibitor for treating triple-negative breast cancer. Breast Cancer Res Treat. 2019;175:553\u201366.","journal-title":"Breast Cancer Res Treat"},{"key":"3163_CR50","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1158\/1535-7163.MCT-15-0921","volume":"15","author":"X Wu","year":"2016","unstructured":"Wu X, Cao Y, Xiao H, Li C, Lin J. Bazedoxifene as a novel GP130 inhibitor for pancreatic cancer therapy. Mol Cancer Ther. 2016;15:2609\u201319.","journal-title":"Mol Cancer Ther"},{"key":"3163_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-00913-w","volume":"9","author":"C Zhang","year":"2025","unstructured":"Zhang C, Jiao S, Zeng D, Jiang W, Wang R, Zheng B, et al. IL-11\/IL-11R signal inhibition by 9MW3811 remodels immune tumor microenvironment and enhances anti-tumor efficacy of PD-1 blockade. npj Precis Oncol. 2025;9:138.","journal-title":"npj Precis Oncol"},{"key":"3163_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04079-6","volume":"21","author":"W Xiong","year":"2023","unstructured":"Xiong W, Chen Y, Zhang C, Li J, Huang H, Zhu Y, et al. Pharmacologic inhibition of IL11\/STAT3 signaling increases MHC-I expression and T cell infiltration. J Transl Med. 2023;21:416.","journal-title":"J Transl Med"},{"key":"3163_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202306348","volume":"11","author":"M Tang","year":"2024","unstructured":"Tang M, Xu M, Wang J, Liu Y, Liang K, Jin Y, et al. Brain metastasis from EGFR-mutated non-small cell lung cancer: secretion of IL11 from astrocytes up-regulates PDL1 and promotes immune escape. Adv Sci. 2024;11:e2306348.","journal-title":"Adv Sci"},{"key":"3163_CR54","doi-asserted-by":"crossref","unstructured":"Szmyd M, Zanib A, Behlow V, Hallman E, Pfiffner S, Yaldo R, et al. Modulation of estrogen receptor alpha (ERalpha) and tumor suppressor gene BRCA1 in breast cancer cells by bazedoxifene acetate (BZA). Cancers. 2024;16:699.","DOI":"10.3390\/cancers16040699"},{"key":"3163_CR55","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3892\/ol.2024.14688","volume":"28","author":"K Caroland","year":"2024","unstructured":"Caroland K, Shi C, Lin J. Synergistic effect of bazedoxifene and abemaciclib co\u2011treatment in triple\u2011negative breast cancer cells in vitro. Oncol Lett. 2024;28:554.","journal-title":"Oncol Lett"},{"key":"3163_CR56","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1177\/0023677213512821","volume":"48","author":"GH Im","year":"2014","unstructured":"Im GH, Jang MS, Chung JJ, Kim KN, Kim JH, Kim SI, et al. Improvement of orthotopic lung cancer mouse model via thoracotomy and orotracheal intubation enabling in vivo imaging studies. Lab Anim. 2014;48:124\u201331.","journal-title":"Lab Anim"},{"key":"3163_CR57","doi-asserted-by":"publisher","first-page":"5340","DOI":"10.1038\/s41388-018-0311-3","volume":"37","author":"K Wang","year":"2018","unstructured":"Wang K, Ji W, Yu Y, Li Z, Niu X, Xia W, et al. FGFR1-ERK1\/2-SOX2 axis promotes cell proliferation, epithelial-mesenchymal transition, and metastasis in FGFR1-amplified lung cancer. Oncogene. 2018;37:5340\u201354.","journal-title":"Oncogene"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03163-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03163-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03163-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T02:57:08Z","timestamp":1786935428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03163-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3163"],"URL":"https:\/\/doi.org\/10.1038\/s41420-026-03163-2","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"20 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All animal experiments were performed in accordance with the relevant guidelines and regulations and were approved by the Institutional Animal Care and Use Committee of Shin Kong Wu Ho-Su Memorial Hospital (IACUC Approval No. 112NSTCIACUC010). Animal handling and reporting were conducted in accordance with the ARRIVE guidelines, where applicable. This study did not involve human participants, human tissue, or identifiable human data; therefore, informed consent was not applicable.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"337"}}